The 1 analysts offering 12-month price forecasts for ARCA Biopharma Inc have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 7.00. The median estimate represents a +208.37% increase from the last price of 2.27.
The current consensus among 1 polled investment analysts is to Buy stock in ARCA Biopharma Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$2.30
Reporting Date Nov 03
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.